Sarute N, Ross SR. New World Arenavirus Biology. Annu Rev Virol. 2017 Sep 29. 4 (1):141-158. [QxMD MEDLINE Link]. [Full Text].
Moraes F, Góes A. A decade of human genome project conclusion: Scientific diffusion about our genome knowledge. Biochem Mol Biol Educ. 2016 May 6. 44 (3):215-23. [QxMD MEDLINE Link].
Bateman C. Arenavirus deaths--emergency air services tighten up. S Afr Med J. 2008 Dec. 98(12):910, 912, 914. [QxMD MEDLINE Link].
Whitby LR, Lee AM, Kunz S, Oldstone MB, Boger DL. Characterization of lassa virus cell entry inhibitors: Determination of the active enantiomer by asymmetric synthesis. Bioorg Med Chem Lett. 2009 May 3. [QxMD MEDLINE Link].
Fichet-Calvet E, Rogers DJ. Risk maps of lassa Fever in west Africa. PLoS Negl Trop Dis. 2009. 3(3):e388. [QxMD MEDLINE Link].
Cosset FL, Marianneau P, Verney G, Gallais F, Tordo N, Pécheur EI, et al. Characterization of Lassa virus cell entry and neutralization with Lassa virus pseudoparticles. J Virol. 2009 Apr. 83(7):3228-37. [QxMD MEDLINE Link].
Vanzee BE, Douglas RG, Betts RF, et al. Lymphocytic choriomeningitis in university hospital personnel. Clinical features. Am J Med. 1975 Jun. 58(6):803-9. [QxMD MEDLINE Link].
CDC. Lymphocytic Choriomeningitis (LCM). Centers for Disease Control and Prevention. Available at https://www.cdc.gov/vhf/lcm/index.html. 6 May 2014; Accessed: 11 May 2019.
Holmes GP, McCormick JB, Trock SC. Lassa fever in the United States. Investigation of a case and new guidelines for management. N Engl J Med. 1990 Oct 18. 323(16):1120-3. [QxMD MEDLINE Link].
CDC. Viral Hemorrhagic Fevers. Centers for Disease Control and Prevention. Available at https://www.cdc.gov/vhf/index.html. 29 Jan 2014; Accessed: 11 May 2019.
Pasquato A, Kunz S. Novel drug discovery approaches for treating arenavirus infections. Expert Opin Drug Discov. 2016. 11 (4):383-93. [QxMD MEDLINE Link].
Furuta Y, Takahashi K, Shiraki K, Sakamoto K, Smee DF, Barnard DL, et al. T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections. Antiviral Res. 2009 Jun. 82(3):95-102. [QxMD MEDLINE Link].
King BR, Hershkowitz D, Eisenhauer PL, Weir ME, Ziegler CM, Russo J, et al. A Map of the Arenavirus Nucleoprotein-Host Protein Interactome Reveals that Junín Virus Selectively Impairs the Antiviral Activity of Double-Stranded RNA-Activated Protein Kinase (PKR). J Virol. 2017 Aug 1. 91 (15):[QxMD MEDLINE Link]. [Full Text].
Banerjee C, Allen LJ, Salazar-Bravo J. Models for an arenavirus infection in a rodent population: consequences of horizontal, vertical and sexual transmission. Math Biosci Eng. 2008 Oct. 5(4):617-45. [QxMD MEDLINE Link].
Biggar RJ, Woodall JP, Walter PD, Haughie GE. Lymphocytic choriomeningitis outbreak associated with pet hamsters. Fifty-seven cases from New York State. JAMA. 1975 May 5. 232(5):494-500. [QxMD MEDLINE Link].
Briese T, Paweska JT, McMullan LK, Hutchison SK, Street C, Palacios G, et al. Genetic detection and characterization of lujo virus, a new hemorrhagic Fever-associated arenavirus from southern Africa. PLoS Pathog. 2009 May. 5(5):e1000455. [QxMD MEDLINE Link].
Buchmeier MJ, et al. Arenaviridae: the viruses and their replication. Knipe DL, and Howley, PM. Field's Virology. 4. Philadelphia, PA: Lippencott-Raven; 2007. 1791-1828.
Buckley SM, Casals J. Pathobiology of Lassa fever. Int Rev Exp Pathol. 1978. 18:97-136. [QxMD MEDLINE Link].
Cao W, Henry MD, Borrow P, et al. Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. Science. 1998 Dec 11. 282(5396):2079-81. [QxMD MEDLINE Link].
Centers for Disease Control and Prevention. Arenavirus infection--Connecticut, 1994. MMWR Morb Mortal Wkly Rep. 1994 Sep 2. 43(34):635-6. [QxMD MEDLINE Link].
Centers for Disease Control and Prevention. Fatal illnesses associated with a new world arenavirus--California, 1999-2000. MMWR Morb Mortal Wkly Rep. 2000 Aug 11. 49(31):709-11. [QxMD MEDLINE Link].
Charrel RN, Coutard B, Baronti C, et al. Arenaviruses and hantaviruses: From epidemiology and genomics to antivirals. Antiviral Res. 2011 May. 90(2):102-14. [QxMD MEDLINE Link].
Cummins D, McCormick JB, Bennett D, et al. Acute sensorineural deafness in Lassa fever. JAMA. 1990 Oct 24-31. 264(16):2093-6. [QxMD MEDLINE Link].
Delgado S, Erickson BR, Agudo R, et al. Chapare virus, a newly discovered arenavirus isolated from a fatal hemorrhagic fever case in Bolivia. PLoS Pathog. 2008 Apr. 4(4):e1000047. [QxMD MEDLINE Link].
Fischer SA, Graham MB, Kuehnert MJ. Transmission of lymphocytic choriomeningitis virus by organ transplantation. N Engl J Med. 2006. 354:2208-11.
Hinman AR, Fraser DW, Douglas RG, et al. Outbreak of lymphocytic choriomeningitis virus infections in medical center personnel. Am J Epidemiol. 1975 Feb. 101(2):103-10. [QxMD MEDLINE Link].
Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ, et al. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature. 1992 Feb 20. 355(6362):696-702. [QxMD MEDLINE Link].
Inegbenebor U, Okosun J, Inegbenebor J. Prevention of lassa Fever in Nigeria. Trans R Soc Trop Med Hyg. 2010 Jan. 104(1):51-4. [QxMD MEDLINE Link].
Jay MT, Glaser C, Fulhorst CF. The arenaviruses. J Am Vet Med Assoc. 2005. 227:904-15.
Khan SH, Goba A, Chu M, et al. New opportunities for field research on the pathogenesis and treatment of Lassa fever. Antiviral Res. 2008 Apr. 78(1):103-15. [QxMD MEDLINE Link].
Kiley MP, Lange JV, Johnson KM. Protection of rhesus monkeys from Lassa virus by immunisation with closely related Arenavirus. Lancet. 1979 Oct 6. 2(8145):738. [QxMD MEDLINE Link].
Kunz S, de la Torre JC. Novel antiviral strategies to combat human Arenavirus infections. Curr Mol Med. 2005. 5:735-51.
Lan S, McLay Schelde L, Wang J, Kumar N, Ly H, Liang Y. Development of infectious clones for virulent and avirulent Pichinde viruses - a model virus to study arenavirus-induced hemorrhagic fevers. J Virol. 2009 Apr 22. [QxMD MEDLINE Link].
Maiztegui JI. Clinical and epidemiological patterns of Argentine haemorrhagic fever. Bull World Health Organ. 1975. 52(4-6):567-75. [QxMD MEDLINE Link].
Maiztegui JI, McKee KT Jr, Barrera Oro JG, et al. Protective efficacy of a live attenuated vaccine against Argentine hemorrhagic fever. AHF Study Group. J Infect Dis. 1998 Feb. 177(2):277-83. [QxMD MEDLINE Link].
McCormick JB, King IJ, Webb PA, et al. Lassa fever. Effective therapy with ribavirin. N Engl J Med. 1986 Jan 2. 314(1):20-6. [QxMD MEDLINE Link].
Paweska JT, Sewlall NH, Ksiazek TG, et al. Nosocomial outbreak of novel arenavirus infection, southern Africa. Emerg Infect Dis. 2009 Oct. 15(10):1598-602. [QxMD MEDLINE Link]. [Full Text].
Peters CJ. Lymphocytic Choriomeningitis Virus, Lassa Virus, and the South American Hemorrhagic Fevers. Gerald L. Mandell, John E. Bennett, Raphael Dolin. Principles and Practice of Infectious Diseases. 7. Philadelphia, PA: Churchill Livingstone Elsevier; 2010. 2: 2295-2302.
Radoshitzky SR, Abraham J, Spiropoulou CF, et al. Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses. Nature. 2007 Mar 1. 446(7131):92-6. [QxMD MEDLINE Link].
Stinebaugh BJ, Schloeder FX, Johnson KM, et al. Bolivian hemorrhagic fever. A report of four cases. Am J Med. 1966 Feb. 40(2):217-30. [QxMD MEDLINE Link].
Zweighaft RM, Fraser DW, Hattwick MA, et al. Lassa fever: response to an imported case. N Engl J Med. 1977 Oct 13. 297(15):803-7. [QxMD MEDLINE Link].
Shao J, Liang Y, Ly H. Human hemorrhagic Fever causing arenaviruses: molecular mechanisms contributing to virus virulence and disease pathogenesis. Pathogens. 2015 May 21. 4 (2):283-306. [QxMD MEDLINE Link].